Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Nicolò

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|February 26, 2025
Combination of <i>Saffron</i> (<i>Crocus sativus</i>), <i>Elderberry</i> (<i>Sambucus nigra</i> L.) and <i>Melilotus officinalis</i> Protects ARPE-19 Cells from Oxidative StressAlessandra Puddu, Massimo Nicolò, Davide C Maggi
European Journal of Ophthalmology|June 7, 2014
Yellow micropulse laser in diabetic macular edema: a short-term pilot studyMassimo Nicolò, Donatella Musetti, Carlo E Traverso
Expert Opinion on Biological Therapy|April 26, 2021
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMDLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Expert Opinion on Investigational Drugs|June 2, 2020
Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degenerationLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Retina (Philadelphia, Pa.)|September 7, 2016
CorrespondenceAldo Vagge, Paola Camicione, Massimo Nicolò, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 9, 2006
Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfinMassimo Nicolò, Davidina Ghiglione, Silvio Lai, et al.
Expert Opinion on Therapeutic Targets|January 31, 2022
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseasesLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Ophthalmology|December 21, 2021
Retinal Pigment Epithelium Tear after Glaucoma SurgeryCarlo A Cutolo, Massimo Nicolò, Carlo E Traverso
American Journal of Ophthalmology|October 25, 2011
Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathyMassimo Nicolò, Daniela Zoli, Maria Musolino, et al.
American Journal of Ophthalmology|August 3, 2014
Chorioretinal folds: associated disorders and a related maculopathyDonatella Musetti, Massimo Nicolò, Alessandro Bagnis, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|February 26, 2025
Combination of <i>Saffron</i> (<i>Crocus sativus</i>), <i>Elderberry</i> (<i>Sambucus nigra</i> L.) and <i>Melilotus officinalis</i> Protects ARPE-19 Cells from Oxidative StressAlessandra Puddu, Massimo Nicolò, Davide C Maggi
European Journal of Ophthalmology|June 7, 2014
Yellow micropulse laser in diabetic macular edema: a short-term pilot studyMassimo Nicolò, Donatella Musetti, Carlo E Traverso
Expert Opinion on Biological Therapy|April 26, 2021
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMDLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Expert Opinion on Investigational Drugs|June 2, 2020
Abicipar pegol: an investigational anti-VEGF agent for the treatment of wet age-related macular degenerationLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Retina (Philadelphia, Pa.)|September 7, 2016
CorrespondenceAldo Vagge, Paola Camicione, Massimo Nicolò, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 9, 2006
Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfinMassimo Nicolò, Davidina Ghiglione, Silvio Lai, et al.
Expert Opinion on Therapeutic Targets|January 31, 2022
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseasesLorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò
Ophthalmology|December 21, 2021
Retinal Pigment Epithelium Tear after Glaucoma SurgeryCarlo A Cutolo, Massimo Nicolò, Carlo E Traverso
American Journal of Ophthalmology|October 25, 2011
Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathyMassimo Nicolò, Daniela Zoli, Maria Musolino, et al.
American Journal of Ophthalmology|August 3, 2014
Chorioretinal folds: associated disorders and a related maculopathyDonatella Musetti, Massimo Nicolò, Alessandro Bagnis, et al.
Pageof 8